The Risk of recurrence in prostate cancer
by: Fritz Frei
Prostate cancer disease
Prostate cancer - the most common form of cancer in men is Prostate cancer, the second leading cause of cancer death. The Main risk factors include age (incidence increases in men over the age of 65 years). It is more prevalent in the western world and about 10% of cases can be linked to family history. The recurrance Rate of the prostate cancer is high.
Mostly, the Prostate cancer is a continuum; progressing through localized, locally advanced, advanced and hormone-refractory stages In general it is a slow growing cancer. He is primarily under hormonal control i.e. testosterone. The choice of treatments which include watchful waiting, surgery (prostatectomy), radiotherapy, hormonal therapy and chemotherapy are dependent on the stage of disease.
1. Most important, that If detected early, using PSA determination, DRE examination and biopsies, and treated appropriately, survival rates are excellent.
2. The most critical focus for the treatment of prostate cancer is to treat those cancers where it is necessary.
3. The Decisions about the best management of prostate cancer can be very complex and depend upon the:
- Pathology of the cancer (unlike other cancers, prostate cancer often progresses very slowly)
- The impact that treatment can have on quality of life, including sexual activity
- Stage of the disease (non-metastatic (localized or locally advanced), metastatic or hormone refractory)
- Age and general health of the patients at diagnosis
- Patient’s preference for treatment
- PSA at diagnosis
4. The treatment options for prostate cancer are:
- Deferred treatment often called ‘watchful waiting’ or 'active surveillance'
- Surgery – Radical Prostatectomy
- Radiotherapy – External Beam and/or Brachytherapy
-Hormonal (endocrine) therapy – Androgen Ablation e.g. anti-androgens, medical castration (LHRHa) or surgical castration
- Palliative Therapy e.g. chemotherapy
- Investigational Therapies
Prostate Cancer Recurrence Rates ***
Prostate cancer is now detected at earlier stages due to heightened awareness and improved screening techniques. Despite definitive therapy, cancer cells may remain and can go undetected for years until they develop into metastatic disease. The risk of recurrence is high, suggesting there is a need to improve treatment approaches. Therefore, it is important to predict pathological stage and risk of disease recurrence early, so that appropriate treatment and/or monitoring can be initiated. The result's of all new treatments will bring us in the future the chance of a lower prostate recurrance.
**You can inform you about the recurrence Rates on:
This gives you an overview with a study case – and the results.
Latest Cancer News:
Cancer-Detecting Yogurt Could Replace Colonoscopies
Engineered yogurt bacteria could make detecting colorectal cancer and other diseases as simple as a pregnancy test. Screening for certain cancers could soon be as simple as a home pregnancy test. Sangeeta Bhatia , a professor at MIT, is working to replace costly and uncomfortable colonoscopies and MRIs with a dollop of yogurt and a urine test?a cheap method that could improve the early diagnosis ... New cancer therapy comes of age, cost a "toxic" side effect
By Ben Hirschler MADRID (Reuters) - A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects -- but their high cost is a growing concern. Drugs that help the body's own immune cells fight tumors are expected to be used in multi-drug cocktails, pushing the price of therapies costing more than $100,000 a year even higher. At the same time, other ... Can Mantis shrimp help fight cancer?
In the seemingly endless fight against cancer, flowers, barks, snakes, scorpions and various toxic sea creatures are part of an ever-growing pharmacopoeia of medicines and tools. Now, research shows that a flamboyantly colorful sea inhabitant, the Mantis shrimp, may possess useful skills in the cancer war as well. Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors
Title: Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors Category: Health News Created: 9/30/2014 12:00:00 AM Last Editorial Review: 10/1/2014 12:00:00 AM Despite insurance, 1 in 3 cancer survivors incur $10,000+ debt
Even those with solid insurance plans find that cancer treatments leave them deep in debt. Joan Lunden's 'Warrior' Fight Against Cancer
St. Joseph's Hospital Health Center Receives CEO Cancer Gold Standard Accreditation
The CEO Roundtable on Cancer has accredited St. Joseph's Hospital Health Center in Syracuse, N.Y. with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of London at bottom of cancer table
Eight of London's NHS trusts score in the bottom 10 of a cancer patient-experience league table. 3D Mammography Leads to Cancer Diagnosis in Hospital President
Sentara Cancer Network has installed 10 Tomosynthesis (3D Mammography) machines in Virginia. Debra Flores, president, Sentara CarePlex Hospital, purchased first machine for system pilot. Sentara Cancer Network is developing a study on 3D versus 2D patients. Debra Flores, president of Sentara CarePlex Hospital, was three months late for her annual mammogram when she drove to the Dorothy G. Hoefer ... For This October: A New Kind of Breast Cancer Awareness
Today ?awareness? needs an update, and a shift in its focus to these 5 points... For This October: A New Kind of Breast Cancer Awareness - Forbes